· 3 issues
The July-August 1980 issue of HealthPAC Bulletin focuses on the intersection of health, environment, and regulation, highlighting the petrochemical industry's push against government oversight at the expense of public health. An article discusses community health in Chicago, emphasizing how environmental factors impact health outcomes more than hospital care. The issue also features insights on the growing urban poor population and its implications for health services, particularly as cities face budget cuts and increased demand for care. Additionally, the issue touches on the role of health educators and the need for collective action in health promotion.
The October-November 1983 issue of HealthPAC Bulletin focuses on the political implications of biotechnology, highlighting the intersection of health policy and technological advancements. Notable articles discuss the impact of the Ethiopian drought on health care in the Horn of Africa, particularly in Eritrea, where local health workers are addressing malnutrition and sanitation amidst ongoing conflict. The issue also touches on the challenges faced by U.S. workers, particularly women, in balancing employment and childcare, emphasizing the need for comprehensive state support. Additionally, there is commentary on the economic disparities in health insurance options, particularly regarding Health Maintenance Organizations (HMOs).
The September-October 1984 issue of HealthPAC Bulletin focuses on the growing income polarization in the U.S. and its detrimental effects on health, particularly during the Reagan administration. Articles highlight the alarming trends of increasing inequality, with the wealthiest gaining while the poorest suffer, as evidenced by statistics from the Urban Institute. A special section on California health issues discusses the impact of Medi-Cal reforms and organizing efforts against workplace hazards related to video display terminals. The issue also critiques the FDA's handling of antibiotic use in animal feed and its implications for public health, emphasizing the tension between regulatory oversight and corporate interests.